{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:33:11Z","timestamp":1790919191141,"version":"4.1.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2008,11,27]],"date-time":"2008-11-27T00:00:00Z","timestamp":1227744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1,6]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Haemolytic uraemic syndrome (HUS) is characterized by microangiopathic haemolytic anaemia, thrombocytopenia and renal failure because of thrombotic microangiopathy (TMA). It may be caused by infection with Shiga toxin-producing enteropathic bacteria (Stx-associated HUS) or with genetic defects in complement alternative pathway (CAP) regulation (atypical HUS). We hypothesized that defective complement regulation could increase host susceptibility to Stx-associated HUS. Hence, we studied the response of mice with heterozygous deficiency of the major CAP regulator, factor H, to purified Stx-2. Stx-2 was administered together with lipopolysaccharide to wild-type and Cfh+\/\u2212 C57BL\/6 animals. Forty-eight hours after administration of the first Stx-2 injection all animals developed significant uraemia. Renal histology demonstrated significant tubular apoptosis in the cortical and medullary areas which did not differ between wild-type or Cfh+\/\u2212 Stx-2-treated mice. Uraemia and renal tubular apoptosis did not develop in wild-type or Cfh+\/\u2212 animals treated with lipopolysaccharide alone. No light microscopic evidence of TMA or abnormal glomerular C3 staining was demonstrable in the Stx-2 treated animals. In summary, Stx-2 administration did not result in TMA in either Cfh+\/\u2212 or wild-type C57BL\/6 mice. Furthermore, haploinsufficiency of factor H did not alter the development of Stx-2-induced renal tubular injury.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2008.03826.x","type":"journal-article","created":{"date-parts":[[2008,11,27]],"date-time":"2008-11-27T13:57:00Z","timestamp":1227794220000},"page":"339-347","source":"Crossref","is-referenced-by-count":20,"title":["Shiga toxin-2 results in renal tubular injury but not thrombotic microangiopathy in heterozygous factor H-deficient mice"],"prefix":"10.1093","volume":"155","author":[{"given":"D","family":"Paix\u00e3o-Cavalcante","sequence":"first","affiliation":[{"name":"Molecular Genetics and Rheumatology Section"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Botto","sequence":"additional","affiliation":[{"name":"Molecular Genetics and Rheumatology Section"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H T","family":"Cook","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Faculty of Medicine, Imperial College, Hammersmith Campus, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M C","family":"Pickering","sequence":"additional","affiliation":[{"name":"Molecular Genetics and Rheumatology Section"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,11,27]]},"reference":[{"key":"2022010404545277500_b1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0889-8588(02)00085-0","article-title":"Current concepts in the diagnosis and management of thrombotic thrombocytopenic purpura","volume":"17","author":"Nabhan","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"2022010404545277500_b2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0140-6736(94)91227-0","article-title":"Haemolytic-uraemic syndrome: basic science","volume":"343","author":"Moake","year":"1994","journal-title":"Lancet"},{"key":"2022010404545277500_b3","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1093\/ndt\/13.8.2154","article-title":"Thrombotic microangiopathy: a challenge with uncertain outcome","volume":"13","author":"Kulzer","year":"1998","journal-title":"Nephrol Dial Transpl"},{"key":"2022010404545277500_b4","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/infdis\/167.2.500","article-title":"Ground beef consumption in noncommercial settings is a risk factor for sporadic Escherichia coli O157:H7 infection in Canada","volume":"167","author":"Le Saux","year":"1993","journal-title":"J Infect Dis"},{"key":"2022010404545277500_b5","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1056\/NEJM198712103172403","article-title":"A severe outbreak of Escherichia coli O157:H7 \u2013 associated hemorrhagic colitis in a nursing home","volume":"317","author":"Carter","year":"1987","journal-title":"N Engl J Med"},{"key":"2022010404545277500_b6","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1042\/bst0200724","article-title":"Protein toxins: mode of action and cell entry","volume":"20","author":"Sandvig","year":"1992","journal-title":"Biochem Soc Trans"},{"key":"2022010404545277500_b7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000187761","article-title":"Verotoxin-binding in human renal sections","volume":"66","author":"Lingwood","year":"1994","journal-title":"Nephron"},{"key":"2022010404545277500_b8","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s004670100660","article-title":"Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome","volume":"16","author":"Ray","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"2022010404545277500_b9","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.5858\/2002-126-1430-TTPATH","article-title":"Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome","volume":"126","author":"Moake","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"2022010404545277500_b10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-2001-15250","article-title":"The role of virulence factors in enterohemorrhagic Escherichia coli (EHEC) \u2013 associated hemolytic-uremic syndrome","volume":"27","author":"Karch","year":"2001","journal-title":"Semin Thromb Hemost"},{"key":"2022010404545277500_b11","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1523-1755.2001.060003831.x","article-title":"Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura","volume":"60","author":"Ruggenenti","year":"2001","journal-title":"Kidney Int"},{"key":"2022010404545277500_b12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/MNH.0b013e3282f0872f","article-title":"Update on evaluating complement in hemolytic uremic syndrome","volume":"16","author":"Kavanagh","year":"2007","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2022010404545277500_b13","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.molimm.2005.11.008","article-title":"Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree","volume":"43","author":"Esparza-Gordillo","year":"2006","journal-title":"Mol Immunol"},{"key":"2022010404545277500_b14","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood"},{"key":"2022010404545277500_b15","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood-2007-04-084533","article-title":"Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome","volume":"111","author":"Fang","year":"2008","journal-title":"Blood"},{"key":"2022010404545277500_b16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2249.2007.03574.x","article-title":"Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals","volume":"151","author":"Pickering","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"2022010404545277500_b17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng912","article-title":"Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H","volume":"31","author":"Pickering","year":"2002","journal-title":"Nat Genet"},{"key":"2022010404545277500_b18","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1128\/iai.58.12.3959-3965.1990","article-title":"Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II","volume":"58","author":"Wadolkowski","year":"1990","journal-title":"Infect Immun"},{"key":"2022010404545277500_b19","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1128\/iai.57.11.3434-3437.1989","article-title":"Bacterial endotoxin both enhances and inhibits the toxicity of Shiga-like toxin II in rabbits and mice","volume":"57","author":"Barrett","year":"1989","journal-title":"Infect Immun"},{"key":"2022010404545277500_b20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1046\/j.1365-2249.1999.00925.x","article-title":"Depletion of liver and splenic macrophages reduces the lethality of Shiga toxin-2 in a mouse model","volume":"116","author":"Palermo","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"2022010404545277500_b21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2249.2000.01103.x","article-title":"Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality","volume":"119","author":"Palermo","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"2022010404545277500_b22","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1523-1755.2002.00502.x","article-title":"Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model","volume":"62","author":"Rutjes","year":"2002","journal-title":"Kidney Int"},{"key":"2022010404545277500_b23","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1128\/iai.61.8.3392-3402.1993","article-title":"Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice","volume":"61","author":"Tesh","year":"1993","journal-title":"Infect Immun"},{"key":"2022010404545277500_b24","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI26007","article-title":"Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice","volume":"115","author":"Motto","year":"2005","journal-title":"J Clin Invest"},{"key":"2022010404545277500_b25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00467-003-1395-7","article-title":"Hemolytic uremic syndrome induced by lipopolysaccharide and Shiga-like toxin","volume":"19","author":"Ikeda","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"2022010404545277500_b26","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2353\/ajpath.2007.060366","article-title":"CXCL1\/KC and CXCL2\/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation","volume":"170","author":"Roche","year":"2007","journal-title":"Am J Pathol"},{"key":"2022010404545277500_b27","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1681\/ASN.2006050419","article-title":"A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease","volume":"17","author":"Keepers","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2022010404545277500_b28","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.4049\/jimmunol.166.11.6820","article-title":"Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice","volume":"166","author":"Robson","year":"2001","journal-title":"J Immunol"},{"key":"2022010404545277500_b29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/infdis\/175.3.611","article-title":"The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection","volume":"175","author":"Karpman","year":"1997","journal-title":"J Infect Dis"},{"key":"2022010404545277500_b30","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1128\/iai.58.8.2438-2445.1990","article-title":"Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7","volume":"58","author":"Wadolkowski","year":"1990","journal-title":"Infect Immun"},{"key":"2022010404545277500_b31","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1172\/JCI116811","article-title":"A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome","volume":"92","author":"Harel","year":"1993","journal-title":"J Clin Invest"},{"key":"2022010404545277500_b32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/mpat.2002.0501","article-title":"Tumour necrosis factor alpha is not an essential component of verotoxin 1-induced toxicity in mice","volume":"32","author":"Wolski","year":"2002","journal-title":"Microb Pathog"},{"key":"2022010404545277500_b33","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/j.1523-1755.2002.kid554.x","article-title":"Protective role of nitric oxide in mice with Shiga toxin-induced hemolytic uremic syndrome","volume":"62","author":"Dran","year":"2002","journal-title":"Kidney Int"},{"key":"2022010404545277500_b34","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.2353\/ajpath.2006.051331","article-title":"Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling","volume":"169","author":"Morigi","year":"2006","journal-title":"Am J Pathol"},{"key":"2022010404545277500_b35","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1046\/j.1523-1755.1999.00278.x","article-title":"Recruitment of renal tubular epithelial cells expressing verotoxin-1 (Stx1) receptors in HIV-1 transgenic mice with renal disease","volume":"55","author":"Liu","year":"1999","journal-title":"Kidney Int"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2008.03826.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/155\/2\/339\/42039085\/j.1365-2249.2008.03826.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/155\/2\/339\/42039085\/j.1365-2249.2008.03826.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T04:59:22Z","timestamp":1641272362000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/155\/2\/339\/6457379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,27]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2008,11,27]]},"published-print":{"date-parts":[[2009,1,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2008.03826.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2009,2]]},"published":{"date-parts":[[2008,11,27]]}}}